Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis

New England Journal of Medicine

Volumn 336, Issue 25, 1997, Pages 1788-1793

  Kemppainen, Esko A ^a   HedstrØm, Johan I ^a   Puolakkainen, Pauli A ^a   Sainio, Vesa S ^a   Haapiainen, Reijo K ^a   Perhoniemi, Vesa ^a   Osman, Sirpa ^a   Kivilaakso, Eero O ^a   Stenman, Ulf Hakan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; TRYPSINOGEN; TRYPSINOGEN 2; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; URINALYSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLASES; FEMALE; FLUOROIMMUNOASSAY; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAGENT STRIPS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRYPSIN; TRYPSINOGEN;

EID: 0030901775     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199706193362504     Document Type: Article

References (29)

1. Steinberg W, Tenner S. Acute pancreatitis, N Eng] J Med 1994;330: 1198-210.
2. Corfield AP, Cooper MJ, Williamson RCN, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 1985;2:403-7.
3. Beger HG, Bittner R, Block S, Buchlcr M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology 1986;91: 433-8.
4. Clavien PA, Burg an S, Moossa AR. Serum enzymes and other laboratory tests in acute pancreatitis. Br J Surg 1989;76:1234-43.
5. Wilson C, Imric CW, Carter DC. Fatal acute pancreatitis. Gut 1988;29: 782-8.
6. Wong ECC, Butch AW, Roscnblum JL, Ladenson JH, Scott MG, The clinicaj chemistry laboratory and acute pancreatitis. Clin Chcm 1993;39: 234-43.
7. Balthazar EJ. CT diagnosis and staging of acute pancreatitis. Radiol Clin North Am 1989;27:19-37.
8. Gunn IR, Fayc S, Clayton MG. Prospective evaluation of urinary amylase test strip. Lancet 1986;1:1161.
9. Burkitt DS. The Rapignost- Amylase test in acute pancreatitis. Br J Surg 1987;74:1063.
10. Rinderknecht H, Geokas MC. Anionic and cationic trypsinogcns (trypsins) in mammalian pancreas. Enzyme 1972/73;14:116-30.
11. Hedstr̈m J, Sainio V, Kcmppainen E, et al. Urine trypsinogen-2 as marker of acute pancreatitis. Clin Chcm 1996;42:685-90.
12. Itkonen O, Koivunen E, Hurmc M, Alfthan H, Schroder T, Stenman U-H. Time-resolved immunofhiorometric assays for trypsinogen-l and 2 in scrum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-8.
13. Kimland M, Russick C, Marks WH, Borgstr̈m A. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta 1989;184: 31-46.
14. Marshall JB. Acute pancreatitis: a review with an emphasis on new developments. Arch Intern Med 1993;153:1185-98.
15. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14:141-5.
16. Hedstr̈m J, Kurvuo A, Kcnkim̈ki P, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet 1996;347:729-30.
17. Bradley EL III. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586-90.
18. Kemppaincn E, Sainio V, Haapiainen R, Kivisaari L, Kivilaakso E, Puolakkainen P. Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis, Br J Surg 1996;83:924-9.
19. Gerhardt W, Waldenstr̈m J, Ḧrder M, et al. SCE Nordic alphaamylasc study. II. Assessment of proposed calibration procedure: a report by the Scandinavian Committee on Enzymes (SCE). Scand J Clin Lab Invest 1986;46:465-9.
20. Armirage P, Berry G. Statistical methods in medical research. 2nd cd. Oxford, England: Blackwell Scientific, 1987.
21. Zweig MH, Campbell G. Receiver-operatig characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39:561-77. [Erratum, Clin Chem 1993;39:1589.]
22. Landis IR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
23. Hedstr̈m J, Haglund C, Haapiaincn R, Stenman U-H. Serum trypsinogen-2 and trypsin-2-alpha,-antitrypsin complex in malignant and benign digestive tract diseases: preferential elevation in patients with cholangiocarcinomas. Int J Cancer I996;66:326-31.
24. Terada T, Nakanuma Y. Immunohistochemical demonstration of pancreatic alpha-amylase and trypsin in intrahepatic bile ducts and pcribiliary glands. Hepatology 1991;14:1129-35.
25. Ohlsson K, Eddeland A. Release of proteolytic enzymes in bileinduced pancreatitis in dogs. Gastroenterology 1975;69:668-75.
26. Hedstr̈m J, Sainio V, Kemppainen E, et al. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ 1996;313:333-7
27. Brooks FP. Testing pancreatic function. N Engl J Mcd 1972;286:300- 3.
28. Clavien PA, Robert JH, Meyer P, et al. Acute pancreatitis and nor-moamylasemia: not an uncommon combination. Arch Surg 1989;210: 614-20.
29. 2, immunoreactivc trypsin, and trypsin inhibitors during human acute pancreatitis. Scand J Gastroenterol 1982;7:413-6.